
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.70 | 0.70 | 0.00 |
Shares | 99.30 | 99.30 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.87 | 23.61 |
Price to Book | 8.04 | 4.56 |
Price to Sales | 5.10 | 3.52 |
Price to Cash Flow | 18.65 | 15.61 |
Dividend Yield | 1.66 | 1.30 |
5 Years Earnings Growth | 9.22 | 10.72 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 25.91 | 14.05 |
Consumer Defensive | 22.37 | 6.14 |
Technology | 20.89 | 27.79 |
Communication Services | 13.90 | 9.05 |
Consumer Cyclical | 9.35 | 12.46 |
Financial Services | 4.87 | 15.09 |
Industrials | 2.71 | 12.43 |
Number of long holdings: 27
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 9.40 | 726.09 | +2.46% | |
Microsoft | US5949181045 | 8.94 | 497.45 | +1.05% | |
Novo Nordisk B | DK0062498333 | 6.50 | 437.5 | +1.51% | |
Stryker | US8636671013 | 6.46 | 390.40 | -0.47% | |
L'Oreal | FR0000120321 | 5.12 | 355.20 | +1.56% | |
ADP | US0530151036 | 4.84 | 302.98 | +1.61% | |
Visa A | US92826C8394 | 4.83 | 346.03 | +0.22% | |
Philip Morris | US7181721090 | 4.67 | 180.66 | +0.59% | |
Waters | US9418481035 | 4.45 | 354.91 | +1.40% | |
Alphabet A | US02079K3059 | 4.40 | 173.54 | +1.68% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity T Acc | 19.63B | -2.52 | 6.64 | 12.35 | ||
Fundsmith Equity I Acc | 19.63B | -2.48 | 6.75 | 12.46 | ||
Fundsmith Equity I Inc | 19.63B | -2.65 | 6.75 | 12.46 | ||
Fundsmith Equity R Acc | 19.63B | -2.72 | 6.11 | 11.78 | ||
Fundsmith Equity R Inc | 19.63B | -2.72 | 6.11 | 11.78 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review